Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIM Center for Personalized Medicine is a private specialty medical practice in Purchase, New York focused on personalized, integrative, and functional medicine for complex chronic and multisystem illnesses. Founded by Dr. Tania Dempsey, the clinic emphasizes root-cause evaluation and individualized care plans using advanced diagnostics and a broad range of in-clinic and supportive therapies. Its clinical focus includes mast cell activation syndrome, Lyme and other tick-borne illnesses, autoimmune and autoinflammatory conditions, dysautonomia, hormonal disorders, and related chronic immune dysregulation. The organization also operates a clinician-backed supplement business and offers services such as IV therapy, peptide therapy, hormone replacement, medical ozone therapy, and supportive oligonucleotide-based interventions. It appears to be a healthcare services provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIM Center for Personalized Medicine.